Serious Infections and Mortality in Association With Therapies for Crohn’s Disease: TREAT Registry
Top Cited Papers
- 1 May 2006
- journal article
- research article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 4 (5), 621-630
- https://doi.org/10.1016/j.cgh.2006.03.002
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm CountyGut, 2004
- Infliximab Maintenance Therapy for Fistulizing Crohn's DiseaseNew England Journal of Medicine, 2004
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Maintenance infliximab for Crohn's disease: the ACCENT I randomised trialThe Lancet, 2002
- Infliximab for the Treatment of Fistulas in Patients with Crohn's DiseaseNew England Journal of Medicine, 1999
- A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's DiseaseNew England Journal of Medicine, 1997
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 1996
- Survival and causes of death in patients with inflammatory bowel disease: A population-based studyGastroenterology, 1992
- Risk of Infectious Complications in Patients Taking GlucocorticosteroidsClinical Infectious Diseases, 1989
- Narcotic Dependence in Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology, 1988